A. O. Smith (AOS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Feb, 2026Executive summary
Achieved record diluted EPS of $3.85 in 2025, up 6% year-over-year, driven by profitability improvements and margin expansion in both North America and Rest of World segments, with net earnings up 2% to $546.2 million on $3.8 billion in sales.
Fourth quarter 2025 net sales were flat at $913 million, while adjusted EPS rose 6% to $0.90, reflecting strong pricing actions and cost management.
Strategic focus remains on portfolio management, innovation, and operational excellence, with growth platforms in boilers, water treatment, and India positioned for 2026.
Closed the Leonard Valve acquisition in January 2026, expanding the water management platform.
Financial highlights
2025 sales: $3.8 billion, with adjusted EPS of $3.85, up from $3.63 in 2024; net earnings (GAAP) were $546.2 million.
Free cash flow reached $546 million, up from $474 million in 2024, representing 100% of net earnings.
Returned $597 million to shareholders via dividends and share repurchases; 5.9 million shares repurchased in 2025.
North America segment margin: 24.4%, up 20 basis points; Rest of World margin: 8.7%, up 40 basis points.
Cash and marketable securities at year-end: $193 million; net cash position: $38 million; leverage ratio: 7.7%.
Outlook and guidance
2026 EPS guidance: $3.85–$4.15, with sales expected to increase 2%–5% to $3.9–$4.02 billion.
Free cash flow projected at $525–$575 million; capital expenditures expected at $70–$100 million.
North America segment margin expected at 24%–24.5%; Rest of World at 8%–10%.
Leonard Valve projected to contribute $70 million in 2026 sales.
Share repurchases projected at $200 million for 2026; projected 2026 diluted shares: 138 million.
Latest events from A. O. Smith
- Proxy details director elections, executive pay, auditor ratification, and enhanced ESG oversight.AOS
Proxy Filing4 Mar 2026 - Q2 sales up 7% to $1.02B, EPS up 5%, 2024 guidance reaffirmed, Pureit deal to close by year-end.AOS
Q2 20243 Feb 2026 - Q3 sales and earnings fell on China and North America softness; 2024 outlook reaffirmed.AOS
Q3 202419 Jan 2026 - 2024 sales and earnings dipped, but 2025 targets margin gains and strong shareholder returns.AOS
Q4 20249 Jan 2026 - Q1 2025 sales fell 2% year-over-year, but 2025 guidance and margin gains remain solid.AOS
Q1 202525 Dec 2025 - Proxy covers director elections, executive pay, auditor ratification, and ESG-linked incentives.AOS
Proxy Filing1 Dec 2025 - Director nominee Adrian I. Peace withdrew; Board reduced to nine, proxy cards remain valid.AOS
Proxy Filing1 Dec 2025 - Q2 2025 EPS rose to $1.07 as margins improved and 2025 guidance was raised.AOS
Q2 20255 Nov 2025 - Q3 2025 sales up 4%, EPS up 15%, North America strong, China down 12%, 2025 EPS $3.70–$3.85.AOS
Q3 202529 Oct 2025